The Future of Parenteral Nutrition

  • About the author
    • Disclaimer
  • EXECUTIVE SUMMARY
    • Introduction
    • Parenteral nutrition in the US & Canada
    • Parenteral nutrition in the EU
    • Opportunities in parenteral nutrition
  • Introduction
    • Summary
    • Introduction
      • Parenteral vs. enteral nutrition
    • Major disease populations for parenteral nutrition
      • Cancer patients
      • Gastrointestinal disease patients
      • AIDS patients
    • Environments for parenteral nutrition
      • Inpatient environments
      • Outpatient environments
    • Major types of parenteral nutrition & product ingredients
      • Central vs. peripheral parenteral nutrition
      • Parenteral vs. total parenteral nutrition (TPN)
      • Standardized vs. individualized formulas
      • Pediatric patients
      • Products and ingredients
      • Alternatives to parenteral nutrition
    • Market summary
    • Conclusion
  • Parenteral nutrition in the US & Canada
    • Summary
    • Introduction
      • Regulation
      • Insurance reimbursement
      • User populations
    • Parenteral nutrition in the US
      • Key products and players
      • Sales and market share, 2009–2014
      • New product development
      • Opportunities
    • Parenteral nutrition in Canada
      • Key products and players
      • Sales and market share, 2009–2014
      • New product development
      • Opportunities
    • Conclusions
  • Parenteral nutrition in the EU
    • Summary
    • Introduction
      • Regulation
      • Insurance Reimbursement
      • User populations
    • Parenteral nutrition in the EU
      • Key products and players
      • Sales and market share
      • New product development
      • Opportunities
    • Conclusions
  • Opportunities in parenteral nutrition
    • Summary
    • Introduction
    • New products and other opportunities by product
      • Improved hardware and accessories
      • Automation
      • Non-intravenous product formats
      • Products for selected disease populations
      • Products designed for home use
      • Combination products
      • Pediatric products
    • Product development strategies of leading parenteral nutrition players
      • B. Braun
      • Baxter
      • Fresenius Kabi
      • Hospira
    • Conclusion
  • Appendix
    • Scope
    • Methodology
      • Secondary research
    • Glossary/Abbreviations
    • References
  • TABLES
    • Table: Indications and contraindications for enteral and parenteral nutrition
    • Table: Patients using parenteral nutrition by condition, 2010
    • Table: Inpatient care facilities in the US, Canada and EU, 2010
    • Table: Basic adult daily requirements for TPN, 2010
    • Table: Basic adult daily requirements for TPN, 2010 (cont.)
    • Table: Sales of parenteral nutrition products ($m), by region and major manufacturer, 2009
    • Table: CMS reimbursement schedule for parenteral nutrition products and accessories, 2009
    • Table: Leading US parenteral nutrition products, 2010
    • Table: Leading Canadian parenteral nutrition products, 2010
    • Table: Leading EU parenteral nutrition products, 2010
    • Table: Demographic data for EU member countries 2006
    • Table: Healthcare data for EU member countries 2006
    • Table: Malnutrition in the EU by country, 2010
    • Table: Selected disease specific clinical nutrition products, 2010
  • FIGURES
    • Figure: Advantages and disadvantages of parenteral nutrition
    • Figure: Major routes of parenteral nutrition
    • Figure: Number of parenteral nutrition patients in the US, Canada & EU, 2009– 14
    • Figure: Sales of parenteral nutrition products ($m), in the US Canada & EU, 2009– 14
    • Figure: Sales of parenteral nutrition products ($m), in the US, Canada and EU by disease population, 2009 - 2014
    • Figure: Sales of parenteral nutrition products ($m), in the US, Canada and EU by major manufacturer, 2009
    • Figure: Number of parenteral nutrition patients in the US and Canada, 2009– 14
    • Figure: US parenteral nutrition market ($m), 2009– 14
    • Figure: Leading US parenteral nutrition players, 2009
    • Figure: US parenteral nutrition market by disease population ($m), 2009– 14
    • Figure: Triple-chamber bag, dual-chamber bag and traditional bag
    • Figure: Canadian parenteral nutrition market ($m), 2009–2014
    • Figure: Leading Canadian parenteral nutrition players, 2009
    • Figure: Canadian parenteral nutrition market ($m), by disease population, 2009– 14
    • Figure: Number of EU parenteral nutrition patients, 2009–14
    • Figure: EU country potential for parenteral nutrition, 2010
    • Figure: Total EU parenteral nutrition market ($m), 2009– 14
    • Figure: Leading EU parenteral nutrition players ($m), 2009
    • Figure: German parenteral nutrition market and patients ($m), 2009– 14
    • Figure: French parenteral nutrition market and patients ($m), 2009– 14
    • Figure: UK parenteral nutrition market and patients ($m), 2009– 14
    • Figure: Italian parenteral nutrition market and patients ($m), 2009– 14
    • Figure: Spanish parenteral nutrition market and patients ($m), 2009– 14
    • Figure: Polish parenteral nutrition market and patients ($m), 2009– 14
    • Figure: EU parenteral nutrition market by disease population ($m), 2009– 14
    • Figure: EU hospital stays vs. home care patients, 1990–2010
    • Figure: Parenteral nutrition opportunities by product type, 2010
    • Figure: TPNstation from Health Robotics, 2010
    • Figure: Strategy and product development activities of leading parenteral nutrition product manufacturers, 2010
    • Figure: Ambix-Active infusion pump from Fresenius Kabi

Report

Published by
Business Insights
Published on
15 Oct 2010
Product code
BI00010-013
Pages
Please wait...

$4795

Multi-user License $17981